Literature DB >> 23737292

Integrin-mediated interactions with extracellular matrix proteins for nucleus pulposus cells of the human intervertebral disc.

D T Bridgen1, C L Gilchrist, W J Richardson, R E Isaacs, C R Brown, K L Yang, J Chen, L A Setton.   

Abstract

The extracellular matrix (ECM) of the human intervertebral disc is rich in molecules that interact with cells through integrin-mediated attachments. Porcine nucleus pulposus (NP) cells have been shown to interact with laminin (LM) isoforms LM-111 and LM-511 through select integrins that regulate biosynthesis and cell attachment. Since human NP cells lose many phenotypic characteristics with age, attachment and interaction with the ECM may be altered. Expression of LM-binding integrins was quantified for human NP cells using flow cytometry. The cell-ECM attachment mechanism was determined by quantifying cell attachment to LM-111, LM-511, or type II collagen after functionally blocking specific integrin subunits. Human NP cells express integrins β1, α3, and α5, with over 70% of cells positive for each subunit. Blocking subunit β1 inhibited NP cell attachment to all substrates. Blocking subunits α1, α2, α3, and α5 simultaneously, but not individually, inhibits NP cell attachment to laminins. While integrin α6β1 mediated porcine NP cell attachment to LM-111, we found integrins α3, α5, and β1 instead contributed to human NP cell attachment. These findings identify integrin subunits that may mediate interactions with the ECM for human NP cells and could be used to promote cell attachment, survival, and biosynthesis in cell-based therapeutics.
Copyright © 2013 Orthopaedic Research Society.

Entities:  

Keywords:  extracellular matrix; human; intervertebral disc; nucleus pulposus, integrin

Mesh:

Substances:

Year:  2013        PMID: 23737292      PMCID: PMC3826265          DOI: 10.1002/jor.22395

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  25 in total

Review 1.  A simplified laminin nomenclature.

Authors:  Monique Aumailley; Leena Bruckner-Tuderman; William G Carter; Rainer Deutzmann; David Edgar; Peter Ekblom; Jürgen Engel; Eva Engvall; Erhard Hohenester; Jonathan C R Jones; Hynda K Kleinman; M Peter Marinkovich; George R Martin; Ulrike Mayer; Guerrino Meneguzzi; Jeffrey H Miner; Kaoru Miyazaki; Manuel Patarroyo; Mats Paulsson; Vito Quaranta; Joshua R Sanes; Takako Sasaki; Kiyotoshi Sekiguchi; Lydia M Sorokin; Jan F Talts; Karl Tryggvason; Jouni Uitto; Ismo Virtanen; Klaus von der Mark; Ulla M Wewer; Yoshihiko Yamada; Peter D Yurchenco
Journal:  Matrix Biol       Date:  2005-08       Impact factor: 11.583

2.  Intervertebral disc degeneration. Summary of an AAOS/NIH/ORS workshop, September 2005.

Authors:  Gunnar B J Andersson; Howard S An; Theodore R Oegema; Lori A Setton
Journal:  J Bone Joint Surg Am       Date:  2006-04       Impact factor: 5.284

3.  Functional integrin subunits regulating cell-matrix interactions in the intervertebral disc.

Authors:  Christopher L Gilchrist; Jun Chen; William J Richardson; Richard F Loeser; Lori A Setton
Journal:  J Orthop Res       Date:  2007-06       Impact factor: 3.494

4.  Hypoxia activates MAPK activity in rat nucleus pulposus cells: regulation of integrin expression and cell survival.

Authors:  Makarand V Risbud; Asha Guttapalli; Todd J Albert; Irving M Shapiro
Journal:  Spine (Phila Pa 1976)       Date:  2005-11-15       Impact factor: 3.468

5.  cDNA cloning and chromosomal localization of human alpha(11) integrin. A collagen-binding, I domain-containing, beta(1)-associated integrin alpha-chain present in muscle tissues.

Authors:  T Velling; M Kusche-Gullberg; T Sejersen; D Gullberg
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

6.  Altered integrin mechanotransduction in human nucleus pulposus cells derived from degenerated discs.

Authors:  Christine Lyn Le Maitre; Jennie Frain; Jane Millward-Sadler; Andrew P Fotheringham; Anthony John Freemont; Judith Alison Hoyland
Journal:  Arthritis Rheum       Date:  2009-02

7.  Isolation, cloning, and sequence analysis of the integrin subunit alpha10, a beta1-associated collagen binding integrin expressed on chondrocytes.

Authors:  L Camper; U Hellman; E Lundgren-Akerlund
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

8.  Expression of integrin subunits in the herniated intervertebral disc.

Authors:  Maosheng Xia; Yue Zhu
Journal:  Connect Tissue Res       Date:  2008       Impact factor: 3.417

9.  Expression of laminin isoforms, receptors, and binding proteins unique to nucleus pulposus cells of immature intervertebral disc.

Authors:  Jun Chen; Liufang Jing; Christopher L Gilchrist; William J Richardson; Robert D Fitch; Lori A Setton
Journal:  Connect Tissue Res       Date:  2009       Impact factor: 3.417

10.  Expression of beta 1 integrins by cultured articular chondrocytes and in osteoarthritic cartilage.

Authors:  R F Loeser; C S Carlson; M P McGee
Journal:  Exp Cell Res       Date:  1995-04       Impact factor: 3.905

View more
  27 in total

Review 1.  The role of extracellular matrix elasticity and composition in regulating the nucleus pulposus cell phenotype in the intervertebral disc: a narrative review.

Authors:  Priscilla Y Hwang; Jun Chen; Liufang Jing; Brenton D Hoffman; Lori A Setton
Journal:  J Biomech Eng       Date:  2014-02       Impact factor: 2.097

Review 2.  The role of laminins in cartilaginous tissues: from development to regeneration.

Authors:  Y Sun; T L Wang; W S Toh; M Pei
Journal:  Eur Cell Mater       Date:  2017-07-21       Impact factor: 3.942

3.  Control of adhesive ligand density for modulation of nucleus pulposus cell phenotype.

Authors:  Marcos N Barcellona; Julie E Speer; Bailey V Fearing; Liufang Jing; Amit Pathak; Munish C Gupta; Jacob M Buchowski; Michael Kelly; Lori A Setton
Journal:  Biomaterials       Date:  2020-04-22       Impact factor: 12.479

4.  RNA binding protein HuR regulates extracellular matrix gene expression and pH homeostasis independent of controlling HIF-1α signaling in nucleus pulposus cells.

Authors:  Hehai Pan; Adam Strickland; Vedavathi Madhu; Zariel I Johnson; Saswati N Chand; Jonathan R Brody; Andrzej Fertala; Zhaomin Zheng; Irving M Shapiro; Makarand V Risbud
Journal:  Matrix Biol       Date:  2018-08-07       Impact factor: 11.583

Review 5.  Understanding nucleus pulposus cell phenotype: a prerequisite for stem cell based therapies to treat intervertebral disc degeneration.

Authors:  Hyowon Choi; Zariel I Johnson; Makarand V Risbud
Journal:  Curr Stem Cell Res Ther       Date:  2015       Impact factor: 3.828

Review 6.  Biomaterials for intervertebral disc regeneration and repair.

Authors:  Robert D Bowles; Lori A Setton
Journal:  Biomaterials       Date:  2017-03-15       Impact factor: 12.479

7.  Defining the phenotype of young healthy nucleus pulposus cells: recommendations of the Spine Research Interest Group at the 2014 annual ORS meeting.

Authors:  Makarand V Risbud; Zachary R Schoepflin; Fackson Mwale; Rita A Kandel; Sibylle Grad; James C Iatridis; Daisuke Sakai; Judith A Hoyland
Journal:  J Orthop Res       Date:  2015-01-21       Impact factor: 3.494

8.  Photocrosslinkable laminin-functionalized polyethylene glycol hydrogel for intervertebral disc regeneration.

Authors:  Aubrey T Francisco; Priscilla Y Hwang; Claire G Jeong; Liufang Jing; Jun Chen; Lori A Setton
Journal:  Acta Biomater       Date:  2013-11-25       Impact factor: 8.947

9.  Regulation of human nucleus pulposus cells by peptide-coupled substrates.

Authors:  Devin T Bridgen; Bailey V Fearing; Liufang Jing; Johannah Sanchez-Adams; Megan C Cohan; Farshid Guilak; Jun Chen; Lori A Setton
Journal:  Acta Biomater       Date:  2017-04-20       Impact factor: 8.947

10.  CCN2 suppresses catabolic effects of interleukin-1β through α5β1 and αVβ3 integrins in nucleus pulposus cells: implications in intervertebral disc degeneration.

Authors:  Cassie M Tran; Zachary R Schoepflin; Dessislava Z Markova; Christopher K Kepler; D Greg Anderson; Irving M Shapiro; Makarand V Risbud
Journal:  J Biol Chem       Date:  2014-01-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.